23m
YD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap
YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced the ...
Life360 (Nasdaq: LIF; ASX: 360), the leading family connection and safety company, today announced that it has completed the acquisition of Nativo, a ...
Gold Hydrogen Ltd. company and executive profile by Barron's. View the latest X5Y company infomation and executive bios.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback